A preliminary analysis of volatile metabolites of human induced pluripotent stem cells along the in vitro differentiation

Cellular metabolism of stem cell biology is still an unexplored field. However, considering the amount of information carried by metabolomes, this is a promising field for a fast identification of stem cells itself and during the differentiation process. One of the goals of such application is the identification of residual pluripotent cells before cell transplantation to avoid the occurrence of teratomas. In this paper, we investigated in vitro the volatile compounds (VOCs) released during human induced pluripotent stem cells (hiPSCs) reprogramming. In particular, we studied hiPSCs differentiation to floating and adherent embryoid bodies until early neural progenitor cells. A preliminary Gas Chromatographic/Mass Spectrometer (GC/MS) analysis, based on a single extraction method and chromatographic separation, indicated 17 volatile compounds whose relative abundance is altered in each step of the differentiation process. The pattern of VOCs shown by hiPSCs is well distinct and makes these cells sharply separated from the other steps of differentiations. Similar behaviour has also been observed with an array of metalloporphyrins based gas sensors. The use of electronic sensors to control the process of differentiation of pluripotent stem cells might suggest a novel perspective for a fast and on-line control of differentiation processes.

[1]  M. Farag,et al.  A Comparative Metabolomics Approach Reveals Early Biomarkers for Metabolic Response to Acute Myocardial Infarction , 2016, Scientific Reports.

[2]  L. Looijenga,et al.  Lessons from human teratomas to guide development of safe stem cell therapies , 2012, Nature Biotechnology.

[3]  Wei Zhang,et al.  Assessment of ovarian cancer conditions from exhaled breath , 2015, International journal of cancer.

[4]  G. Novelli,et al.  Human induced pluripotent stem cells for monogenic disease modelling and therapy. , 2016, World journal of stem cells.

[5]  Ping Wang,et al.  A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis , 2007, Cancer.

[6]  C. Hoeschen,et al.  Discrimination of cancerous and non-cancerous cell lines by headspace-analysis with PTR-MS , 2010, Analytical and bioanalytical chemistry.

[7]  Edward T. Zellers,et al.  Chapter 3 – Acoustic Wave Sensors and Responses , 1997 .

[8]  Jay W. Grate,et al.  Acoustic Wave Sensors , 1996 .

[9]  F. Brancati,et al.  Generation of Human Induced Pluripotent Stem Cells from Extraembryonic Tissues of Fetuses Affected by Monogenic Diseases. , 2015, Cellular reprogramming.

[10]  Jiangjiang Zhu,et al.  Fast Detection of Volatile Organic Compounds from Bacterial Cultures by Secondary Electrospray Ionization-Mass Spectrometry , 2010, Journal of Clinical Microbiology.

[11]  Zhongping Huang,et al.  Characterization of Volatile Organic Metabolites in Lung Cancer Pleural Effusions by SPME–GC/MS Combined with an Untargeted Metabolomic Method , 2014, Chromatographia.

[12]  Jarrett Rosenberg,et al.  Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. , 2011, The Journal of clinical investigation.

[13]  N. Benvenisty,et al.  The tumorigenicity of human embryonic and induced pluripotent stem cells , 2011, Nature Reviews Cancer.

[14]  Tomas Mikoviny,et al.  Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro. , 2009, Anticancer research.

[15]  L. Buck,et al.  Combinatorial Receptor Codes for Odors , 1999, Cell.

[16]  O. Fiehn,et al.  Induced Pluripotent Stem Cells Show Metabolomic Differences to Embryonic Stem Cells in Polyunsaturated Phosphatidylcholines and Primary Metabolism , 2012, PloS one.

[17]  Shannon E. Stitzel,et al.  Artificial noses. , 2011, Annual review of biomedical engineering.

[18]  Giorgio Pennazza,et al.  The lung cancer breath signature: a comparative analysis of exhaled breath and air sampled from inside the lungs , 2015, Scientific Reports.

[19]  Ulrike Tisch,et al.  Classification of lung cancer histology by gold nanoparticle sensors. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[20]  Charles Y. Lin,et al.  Transcriptional Amplification in Tumor Cells with Elevated c-Myc , 2012, Cell.

[21]  Anton Amann,et al.  Analysis of volatile organic compounds (VOCs) in the headspace of NCI-H1666 lung cancer cells. , 2011, Cancer biomarkers : section A of Disease markers.

[22]  Roberto Paolesse,et al.  Investigation of VOCs associated with different characteristics of breast cancer cells , 2015, Scientific Reports.

[23]  R. Goodacre,et al.  Metabolic Profiling: Its Role in Biomarker Discovery and Gene Function Analysis , 2003, Springer US.

[24]  I. Jolliffe.  Principal Component Analysis , 2002 .

[25]  Seung-Woo Lee,et al.  In vitro detection of small molecule metabolites excreted from cancer cells using a Tenax TA thin-film microextraction device. , 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[26]  Massimo Corradi,et al.  Lung cancer biomarkers in exhaled breath , 2011, Expert review of molecular diagnostics.

[27]  R. M. Lec,et al.  Acoustic wave sensors , 2014 .

[28]  J. Herbig,et al.  On-line breath analysis with PTR-TOF , 2009, Journal of breath research.

[29]  M. Barker,et al.  Partial least squares for discrimination , 2003 .

[30]  N. Benvenisty,et al.  Chemical ablation of tumor-initiating human pluripotent stem cells , 2014, Nature Protocols.

[31]  E. Martinelli,et al.  Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. , 2003, Biosensors & bioelectronics.

[32]  J. Pawliszyn,et al.  A critical review in calibration methods for solid-phase microextraction. , 2008, Analytica chimica acta.

[33]  Peter J Sterk,et al.  Exhaled Molecular Fingerprinting in Diagnosis and Monitoring: Validating Volatile Promises. , 2015, Trends in molecular medicine.

[34]  I. Weissman,et al.  Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies , 2013, Nature Medicine.

[35]  Mi-Ok Lee,et al.  In situ label-free quantification of human pluripotent stem cells with electrochemical potential. , 2016, Biomaterials.

[36]  W. Miekisch,et al.  Breath gas aldehydes as biomarkers of lung cancer , 2009, International journal of cancer.

[37]  Radu Ionescu,et al.  Volatile fingerprints of cancer specific genetic mutations. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[38]  Hossam Haick,et al.  Sniffing the unique "odor print" of non-small-cell lung cancer with gold nanoparticles. , 2009, Small.

[39]  Age K. Smilde,et al.  UvA-DARE ( Digital Academic Repository ) Assessment of PLSDA cross validation , 2008 .

[40]  Changsung Kim.  Disease modeling and cell based therapy with iPSC: future therapeutic option with fast and safe application , 2014, Blood research.

[41]  B. de Lacy Costello,et al.  A review of the volatiles from the healthy human body , 2014, Journal of breath research.